Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of $3.70 million. The enterprise value is $3.35 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 30.12 million shares outstanding. The number of shares has increased by 287.99% in one year.
| Current Share Class | 30.12M |
| Shares Outstanding | 30.12M |
| Shares Change (YoY) | +287.99% |
| Shares Change (QoQ) | +0.82% |
| Owned by Insiders (%) | 11.71% |
| Owned by Institutions (%) | 21.07% |
| Float | 26.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 82.44 |
| Forward PS | n/a |
| PB Ratio | -0.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 101.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31
| Current Ratio | 0.31 |
| Quick Ratio | 0.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.45 |
Financial Efficiency
Return on equity (ROE) is -115.65% and return on invested capital (ROIC) is -19.77%.
| Return on Equity (ROE) | -115.65% |
| Return on Assets (ROA) | -6.38% |
| Return on Invested Capital (ROIC) | -19.77% |
| Return on Capital Employed (ROCE) | 115.88% |
| Revenue Per Employee | $3,284 |
| Profits Per Employee | -$629,663 |
| Employee Count | 10 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.23% in the last 52 weeks. The beta is 0.51, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -95.23% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 29.14 |
| Average Volume (20 Days) | 3,469,853 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XAGE had revenue of $32,839 and -$6.30 million in losses. Loss per share was -$0.29.
| Revenue | 32,839 |
| Gross Profit | 27,707 |
| Operating Income | -4.32M |
| Pretax Income | n/a |
| Net Income | -6.30M |
| EBITDA | -4.24M |
| EBIT | -4.32M |
| Loss Per Share | -$0.29 |
Full Income StatementBalance Sheet
The company has $1.14 million in cash and $781,703 in debt, giving a net cash position of $355,622 or $0.01 per share.
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 781,703 |
| Net Cash | 355,622 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | -4.06M |
| Book Value Per Share | -0.19 |
| Working Capital | -4.29M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.03M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
| Gross Margin | 84.37% |
| Operating Margin | -13,169.21% |
| Pretax Margin | -29,675.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |